Organoid monolayers: a patient-relevant platform to study intestinal barrier function, inflammatory bowel disease (IBD), and GI toxicity

October 24, 2023

Organoid monolayers: a patient-relevant platform to study intestinal barrier function, inflammatory bowel disease (IBD), and GI toxicity

read more

Human kidney patient-derived organoids are a promising tool for modeling drug-induced nephrotoxicity and for assessing preclinical toxicity of immunotherapy

September 28, 2023

Human kidney patient-derived organoids are a promising tool for modeling drug-induced nephrotoxicity and for assessing preclinical toxicity of immunotherapy

read more

Human liver patient-derived HUB Organoids as a promising tool to study drug-induced liver injury and drug metabolism for improved preclinical toxicology assessment

October 6, 2022

Human liver patient-derived HUB Organoids as a promising tool to study drug-induced liver injury and drug metabolism for improved preclinical toxicology assessment

read more

HUB Organoids applications to drug safety and ADME evaluation

February 17, 2022

HUB Organoids applications to drug safety and ADME evaluation

read more

Potential of liver organoids in preclinical evaluation of toxicity, safety and mode of action

February 17, 2022

Potential of liver organoids in preclinical evaluation of toxicity, safety and mode of action

read more

X

Have any questions?

contact us